Akshay Chellappa

Akshay Chellappa is a seasoned professional in corporate development and transactions, currently serving as the Director of Corporate Development, Transactions and Director of Global CD Strategy at Gilead Sciences since October 2019. Prior experience includes holding the position of Engagement Manager at Syneos Health, focusing on Transactions Advisory from March 2016 to September 2019, and serving as Senior Manager of Business Development at Endo Pharmaceuticals from September 2011 to March 2016. Akshay has a strong foundation in scientific roles, having been a Scientist at Novel Laboratories, Inc. and holding a brief position as Managing Partner at Spearhead Innovation Venture Capital in 2008. Academic credentials include an MBA in Strategy and Finance from Rutgers Business School, a Master of Science in Biomedical from Rutgers University, and two Bachelor of Science degrees in Biotechnology and Medical Technology from Ferris State University and Lander University, respectively.